Safety and Efficacy Findings for Acalabrutinib Plus Bendamustine and Rituximab in MCL OncLive 1:51 5 years ago 203 Скачать Далее
Dr. Phillips on the Safety of Acalabrutinib Plus Bendamustine/Rituximab in MCL OncLive 1:06 5 years ago 103 Скачать Далее
Acalabrutinib in combination with bendamustine & rituximab in treatment-naïve or R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 1 year ago 249 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in MCL & the importance of chemotherapy-free regimens VJHemOnc – Video Journal of Hematology & HemOnc 3:42 1 year ago 269 Скачать Далее
Rationale for Combining Acalabrutinib With Bendamustine and Rituximab in MCL Targeted Oncology 1:14 5 years ago 208 Скачать Далее
Acalabrutinib and rituximab as first-line therapy for older patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 448 Скачать Далее
Dr. Wang on Addition of Acalabrutinib to Bendamustine/Rituximab in MCL OncLive 1:07 4 years ago 169 Скачать Далее
Dr. Jacobs on the Efficacy of Ibrutinib and Acalabrutinib in Patients With MCL OncLive 1:33 6 years ago 395 Скачать Далее
ASCEND final results: Acalabrutinib vs idelalisib plus rituximab or bendamustine plus rituximab ... ecancer 3:34 4 years ago 70 Скачать Далее
SYMPATICO: safety and efficacy of ibrutinib plus venetoclax for R/R MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:18 3 years ago 87 Скачать Далее
Phase II trial of acalabrutinib, lenalidomide and rituximab in patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 5:12 1 year ago 128 Скачать Далее
Acalabrutinib plus venetoclax and rituximab in the treatment of MCL VJHemOnc – Video Journal of Hematology & HemOnc 0:26 2 years ago 128 Скачать Далее
Bruce D. Cheson, MD discusses the efficacy and safety of acalabrutinib in relapsed/refractory MCL OBRoncology 1:15 6 years ago 40 Скачать Далее
Acalabrutinib monotherapy in R/R MCL: extended follow-up results VJHemOnc – Video Journal of Hematology & HemOnc 3:42 3 years ago 168 Скачать Далее
ASCEND: Acalabrutinib versus rituximab with idelalisib or bendamustine in relapsed or refractory... ecancer 3:27 5 years ago 61 Скачать Далее
Bendamustine/Rituximab as Induction Therapy in MCL Targeted Oncology 1:37 4 years ago 399 Скачать Далее
Dr. Wang on the Toxicity of Ibrutinib, Acalabrutinib, and Zanubrutinib in MCL OncLive 1:10 4 years ago 938 Скачать Далее
Selecting BTK inhibitors for patients with MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:32 1 year ago 165 Скачать Далее
First results of a prospective bendamustine/rituximab trial in patients with MCL ecancer 5:28 7 years ago 455 Скачать Далее
